Cholangiocarcinoma: shedding light on the most promising drugs in clinical development-Reference-Cited by-同舟云学术

Cholangiocarcinoma: shedding light on the most promising drugs in clinical development

Published:2021-03-07 Issue:4 Volume:30 Page:419-427
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Rahnemai-Azar Amir A.¹,Pawlik Timothy M.²

Affiliation:

1. Division of Surgical Oncology, Department of Surgery, Arrowhead Regional Cancer Center, California University of Science and Medicine, Colton, CA, USA

2. Department of Surgery, The Ohio State University Wexner Medical Center, The James Comprehensive Cancer Center, Columbus, OH, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1897103

Reference93 articles.

1. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

2. Cholangiocarcinoma

3. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

4. Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature

5. The Global Burden of Cancer 2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-09

2. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment;Journal of Gastrointestinal Cancer;2022-01-13

3. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs;Expert Opinion on Pharmacotherapy;2021-12-29

4. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma;Hepatic Medicine: Evidence and Research;2021-11

5. Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance;Cancers;2021-05-13